ŒSIV as a model for HIV infection
Dr. Watkins has an extensive background in vaccine research using the Indian rhesus macaque to test vaccine concepts. He has conducted more than 10 vaccine trials in Indian rhesus macaques using a variety of regimens and challenge models. His main interests lie in finding T cell and antibody-based vaccines for several pathogens. He has worked with Brazilian collaborators both at FIOCRUZ and at the University of São Paulo for the last several years and has co-authored multiple publications with them. More recently his laboratory has developed a facility in culturing and measuring viral concentrations and immune responses against flaviviruses as a direct result of the use of recombinant YF17D as a vaccine vector. Dr. Watkins’ extensive experience in testing vaccine approaches in NHP gives him the necessary background to develop vaccine for HTLV-1.
Date:
25 August 2015, 13:00 (Tuesday, 18th week, Trinity 2015)
Venue:
Medawar Building, off South Parks Road OX1 3SY
Venue Details:
Seminar Room 30, Call 281231on arrival for entry
Speaker:
Professor David I. Watkins (University of Miami Miller School of Medicine, Miami, FL)
Organising department:
Nuffield Department of Clinical Medicine
Organisers:
Prof. Philip Goulder (University of Oxford),
Chris Willberg (NDM Experimental Medicine)
Part of:
Peter Medawar Building Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Chris Willberg
